advancements in bispecific and trispecific antibodies for the treatment of lymphoma
Published 2 months ago • 166 plays • Length 2:39Download video MP4
Download video MP3
Similar videos
-
7:05
developments in the use of bispecific antibodies in myeloma and challenges in this space
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all
-
1:48
the potential of bispecific antibody-containing combinations in patients with b-cell lymphomas
-
2:56
the exciting future of bispecific antibodies
-
1:04
immunotherapies in the future treatment landscape for waldenström's macroglobulinemia
-
1:51
sub-typing waldenström's macroglobulinemia: memory b-cell subtype and plasma cell-like subtype
-
1:28
advancements in mrd testing for waldenström's macroglobulinemia: the ddpcr technique
-
1:24
the potential role of non-covalent btkis in mitigating covalent btki resistance
-
0:49
the importance of basic science research in hemoglobinopathies
-
1:26
expanding trials using bispecifics
-
1:33
all diagnostics: challenges and considerations
-
3:37
challenges and unmet needs in mpns: transplant decision-making and the management of mpn-ap/bp
-
2:07
advancements in clinical trials for high-risk newly diagnosed multiple myeloma
-
1:38
challenges with the identification of all subtypes
-
7:25
ai in hematology: advances, challenges, and future applications
-
0:45
cys-ser mutation-driven ibrutinib resistance and alternative btki’s under development
-
1:47
abnormal serum immunofixation patterns following bcma car-t in multiple myeloma
-
1:46
updated analyses from the pathfinder trial: avapritinib therapy in advanced systemic mastocytosis
-
3:32
the challenges with implementing ai in cancer care: building trust in ai technologies